Mortality within three months after nonfatal ischemic stroke treated by mechanical thrombectomy in routine care : data from the German Stroke Registry
Loading...
Date issued
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Reuse License
Abstract
Background
Mechanical thrombectomy (MT) is a highly effective treatment for large vessel occlusion (LVO) ischemic stroke. However, a substantial share of patients have lethal outcome within 3 months. Individualization of outcome prognostication is needed to support clinical decision-making throughout the care pathway after MT. We investigate predictors of lethal outcome in patients with nonfatal LVO, defined by discharge alive from primary treating hospital, in a large prospective registry study of MT under routine care conditions.
Methods
6,518 patients with nonfatal LVO treated by MT enrolled in the German Stroke Registry-Endovascular Treatment from May 2015-December 2021 were analysed with regard to lethal outcome by 3 month follow-up. Univariate group comparisons and multiple logistic regression analysis were performed to identify patients with high odds for survival or lethal outcome.
Results
We report 11.6% (757/6,518) 3 month mortality following hospital discharge after LVO treated by MT. Besides better functional outcome at discharge (modified Rankin scale < 4, odds ratio, OR [95% confidence interval, CI]: 2.38 [1.71–3.32], p < 0.001; National Institute of Health Stroke scale < 8, OR [95%CI]: 3.45 [2.55–4.66], p < 0.001), intravenous thrombolysis (OR [95%CI]: 1.48 [1.17–1.88], p = 0.001), successful recanalization (OR [95%CI]: 1.43 [1.08–1.90], p = 0.014) and discharge to a neurorehabilitative facility (versus nursing home: OR [95%CI]: 0.39 [0.26–0.58], p < 0.001; versus home: OR [95%CI]: 0.69 [0.49–0.97], p = 0.032) were independent predictors of survival. Predictors of lethal outcome were older age (OR [95%CI]: 1.09 [1.07–1.10], p < 0.001), male sex (OR [95%CI]: 1.24 [1.00–1.55], p = 0.049), premorbid disability (OR [95%CI]: 1.47 [1.08–2.02], p = 0.016), active smoking (OR [95%CI]: 1.51 [1.06–2.14], p = 0.023), anticoagulation therapy prior to LVO (OR [95%CI]: 1.45 [1.09–1.92], p = 0.010), stroke etiology, general anaesthesia during MT (OR [95%CI]: 1.31 [1.02–1.69], p = 0.035) and intracerebral haemorrhage (OR [95%CI]: 1.50 [1.13–1.99], p = 0.005).
Conclusions
Lethal outcome after hospital discharge within 3 months after MT is frequent, accounting for more than one quarter of overall 3-month mortality after MT of LVO. Predictors of survival enable individual outcome prognostication, which assists clinical decision-making with regard to surveillance concerning complications, rehabilitative resource allocation and counselling about goals of care.
Description
Keywords
Citation
Published in
Neurological research and practice, 7, Biomed Central, London, 2025, https://doi.org/10.1186/s42466-025-00427-7